Research article · 16 Feb 2026
Review articlePublished 2013
Heart Rate as a Therapeutic Target for the Prevention of Cardiovascular Disease
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Evidence from epidemiologic studies demonstrates that resting Heart Rate (HR) is an independent risk factor for Cardiovascular (CV) event. In addition, recent studies indicate that follow-up HR adds prognostic information over and above baseline HR. Elevated resting HR represents sympathetic over-activation leading to cardiometabolic deterioration and is also associated with subclinical inflammation and target organ damage. In addition, elevated resting HR might modify the local hemodynamic environment and contribute to atherosclerosis formation. A pure HR-lowering drug, Ivabradine, reduces CV event in patients with coronary artery disease and chronic heart failure. These findings indicate that elevated resting HR is not just as an epiphenomenon representing “poor conditioning” but a therapeutic target. The potential role of HR and its modulation should be considered in the future guidance documents.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Angiology: Open Access.
Research article · 16 Feb 2026
Risk Prediction Models for Autogenous Arteriovenous Fistula Maturation Failure in Patients with End-Stage Renal Disease: A Systematic Review and Meta-Analysis
Short communication · 19 Dec 2025
Innovations in Venous Insufficiency Treatment Comparing the Efficacy of Endovenous Laser and Radiofrequency Ablation
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAngiology: Open Access
- SubjectCardiology
- BylineArticles whose byline prints “Taku Inoue”
